Position in LQDA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,353,497
+$3,559,788 QoQ
Shares Held
54,603
+159.6% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#87
of 333 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 11%
Shared 0%
None 89%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026LOS ANGELES CAPITAL MANAGEMENT LLC holds $64,712,202 across 30 Drug Manufacturers - Specialty & Generic names. LQDA ranks #3 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
203,548 | $34,305,979 | |
| 2 | VTRS |
Viatris Inc
|
751,406 | $11,932,327 | |
| 3 | LQDA |
Liquidia Corp
This page
|
54,603 | $4,353,497 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
50,786 | $3,247,764 | |
| 5 | COLL |
Collegium Pharmaceutical, Inc
|
89,443 | $3,237,836 | |
| 6 | PAHC |
Phibro Animal Health Corp
|
67,083 | $2,106,406 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
342,293 | $1,441,053 | |
| 8 | AKBA |
Akebia Therapeutics, Inc.
|
531,813 | $606,266 |
All Filings in LQDA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,353,497 | 54,603 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $793,709 | 21,031 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $946,371 | 27,439 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $585,782 | 25,760 | Shares | Sole | 2025-10-20 | |
| No filing history on record for this holder in this stock. | ||||||